Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$78,317,744
-$28,800,898 QoQ
Shares Held
1,835,859
-17.4% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#30
of 712 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. SNY ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
173,392 | $207,971,583 | |
| 2 | ABBV |
AbbVie Inc.
|
751,485 | $189,103,685 | |
| 3 | GSK |
GSK plc
|
2,767,591 | $145,077,119 | |
| 4 | NVS |
Novartis AG
|
740,532 | $116,056,174 | |
| 5 | SNY |
Sanofi
This page
|
1,835,859 | $78,317,744 | |
| 6 | JNJ |
Johnson & Johnson
|
307,423 | $78,076,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,429 | $5,865,839 | |
| 8 | MRK |
Merck & Co., Inc.
|
38,087 | $4,894,179 |
All Filings in SNY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,317,744 | 1,835,859 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $107,118,642 | 2,223,301 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $49,604,915 | 1,023,626 | Shares | Sole | 2026-02-10 | |
| 2024-09-30 | $8,727,775 | 151,445 | Shares | Sole | 2024-11-08 | |
| 2023-12-31 | $2,169,322 | 43,622 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,860,288 | 34,681 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $14,558,200 | 382,909 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $34,100,698 | 681,605 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $24,697,979 | 481,067 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,933,192 | 118,427 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,799,056 | 141,030 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,345,423 | 44,539 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,055,359 | 41,556 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,623,489 | 33,412 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $760,627 | 15,161 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||